Concepedia

Author

A van der Sluys Veer

Leiden University

Also Known As

A VANDERSLUYSVEER, A van der Sluys Veer, A. VAN DER SLUYS VEER, A. Van Der Sluys Veer, A. van der Sluys Veer, A. van der Sluys Veer, I. Biemond, H., Annet Van Der Sluys Veer, Annet v. d. Sluys Veer, Annet van der Sluys Veer

22

Publications

507

Citations

13

H-Index

23

Concepts

All Affiliations

Leiden UniversityOLVGErasmus MCRijnstate HospitalAmsterdam UMC Location University of Amsterdam
AV

About

A van der Sluys Veer is an author at Leiden University specializing in medicine, autoimmune disease, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

112

2

Gastroenterology

2

2

80

3

Hepatology

2

2

40

4

Immunology

2

2

72

5

Health Sciences

1

1

59

A van der Sluys Veer

×

12

Publications

396

Citations

12

H-Index

YearCitations

Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine.

E.F.M. Posthuma, R. G. J. Westendorp, A van der Sluys Veer,

Gut

1995

93

Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease.

J. W. Arndt, A van der Sluys Veer, D. Blok,

PubMed

1993

59

Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease

Theo Mulder, A van der Sluys Veer, Hein W. Verspaget,

Journal of Gastroenterology and Hepatology

1994

42

MR Colonography with Limited Bowel Preparation: Patient Acceptance Compared with That of Full-Preparation Colonoscopy

Jasper Florie, Erwin Birnie, Rogier E. van Gelder,

Radiology

2007

38

γ‐Glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon‐α‐2b in chronic hepatitis C non‐responders

Jan Maarten Vrolijk, Peter van der Schaar, Brigitte Vroom,

Liver International

2007

32

Sofosbuvir plus simeprevir for the treatment of <scp>HCV</scp> genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life

Sophie B. Willemse, Lubbertus C. Baak, Sjoerd D. Kuiken,

Journal of Viral Hepatitis

2016

25

Fecal Lysozyme in Assessment of Disease Activity in Inflammatory Bowel Disease

A van der Sluys Veer, J. Brouwer, Izäk Biemond,

Digestive Diseases and Sciences

1998

21

MR, CT, and Ultrasound Findings of Metastatic Vipoma in Pancreas

Richenel T.O. Tjon A Tham, Jan B.�M.�J. Jansen, Theo H. M. Falke,

Journal of Computer Assisted Tomography

1989

21

Budesonide and prednisolone suppress peripheral blood natural killer cells in Crohn's disease

A. J. H. M. van IERSSEL, A van der Sluys Veer, Hein W. Verspaget,

Alimentary Pharmacology & Therapeutics

1995

21

No beneficial effects of amantadine in treatment of chronic hepatitis C patients

Hanneke van Soest, Peter Schaar, Ger H. Koek,

Digestive and Liver Disease

2009

19

Page 1